 Proactive Investors UK |
VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma
Trading Markets (press release) This study is the first of two further trials with RPL554 in patients with allergic asthma. Based on the results, it will determine the dosage used in a … Verona Pharma starts Asthma drug trial STOCKS NEWS UK-Verona gains positive update on key drug Verona Pharma up 20% on new drug trial |
View full post on asthma – Google News